FGFR4

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA027273

Antibody HPA027369

Antibody HPA028251

Antibody CAB005196

Tissue

Antibody staining

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

A majority of colorectal, breast, testicular and thyroid cancers as well as several ovarian cancers and malignant melanomas displayed moderate cytoplasmic staining. Remaining malignancies were in general weakly stained or negative. Moderate cytoplasmic positivity was observed in most malignancies. Hepatocellular carcinomas were strongly stained. Several renal cancers, malignant lymphomas, melanomas and gliomas were weakly stained.Colorectal cancer and a few cases of breast, renal, pancreatic and liver cancers showed moderate cytoplasmic positivity. Remaining malignancies were weakly stained or negative.Prostate cancers along with several malignant gliomas, gastric and pancreatic cancers showed strong cytoplasmic positivity. Several colorectal, breast, urothelial, gastric, pancreatic and liver cancers were moderately stained. Remaining malignant cells were weakly stained or negative.

Literature conformity

Partly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected